Virtuoso Therapeutics
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Website
www.virtuosotherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Virtuoso Therapeutics
Virtuoso Therapeutics specializes in developing novel bispecific antibodies aimed at treating complex diseases, particularly cancer. The company employs a unique approach to antibody engineering, leveraging advanced technology and insights to create therapies with superior profiles. Their focus is on improving existing treatments and addressing specific challenges associated with current therapies. With a team of global experts, Virtuoso Therapeutics is positioned to lead the development of innovative bispecific antibody therapies.Explore more
Popular SearchesVirtuoso Therapeutics IncVivace Therapeutics IncSIC Code 28,283NAICS Code 32,325Show moreVirtuoso Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Virtuoso Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Virtuoso Therapeutics recently announced quarterly report
Click to see if Virtuoso Therapeutics had a recent Job posting/layoffs
Virtuoso Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Virtuoso Therapeutics
Check out if Virtuoso Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Virtuoso Therapeutics has new funding data
Check if Virtuoso Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Virtuoso Therapeutics launches new products
Recommended Actions
Reach out to Masked Content who joined Virtuoso Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Virtuoso Therapeutics
Compare insights from companies similar to Virtuoso Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Virtuoso Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Virtuoso Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Virtuoso Therapeutics.
Virtuoso Therapeutics Tech Stack
A closer look at the technologies used by Virtuoso Therapeutics
See more technologies
Virtuoso Therapeutics News & Media
Virtuoso Therapeutics to Present Preclinical Findings on Two Best-in-Class Bispecific Programs at the 2022 American Association for Cancer Research (AACR) Annual Meeting
SAN MATEO, Calif., March 23, 2022 /PRNewswire/ -- Virtuoso Therapeutics, Inc., a private oncology-focused company developing novel bispecific antibody and antibody drug conjugate (ADC) therapies, today announced that it will present two posters highlighting the preclinical data from...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Virtuoso Therapeutics
Sign Up For FreeTo access detailed company insights
Virtuoso Therapeutics specializes in developing novel bispecific antibodies aimed at treating complex diseases, particularly cancer. The company employs a unique approach to antibody engineering, leveraging advanced technology and insights to create therapies with superior profiles. Their focus is on improving existing treatments and addressing spe... Read More
